Skip to content
RVBA-BIOGEPrivate

Biogen

US
Decarbonisation trajectory · all scopes
Scope 1 + 2· base 2021 · 63k tCO2eScope 3· base 2021 · 406k tCO2e

No targets available; showing actuals against baseline.

Headline intensities

Reporting year 2024·Values in USD ($)
Peer cohort: · lower is better
Revenue intensity
Carbon / $m revenue
33.5tCO2e / $m

Carbon per million dollars of revenue. The legacy industry-standard reference (CDP, MSCI). Useful for cross-sector context, but distorted by margin — high-margin firms appear artificially efficient. Read alongside the operational and asset intensities for the full picture.

no peer comparison yet
Operational intensity
Carbon / $m OpEx
tCO2e / $m

OpEx (operating expenditure) is the running cost of the business — staff, services, energy, materials. This shows how carbon-intensive operations are per million dollars of spend. Removes the margin distortion that revenue-based ratios introduce.

no peer comparison yet
Economic intensity
Carbon / $m EVIC
tCO2e / $m

EVIC (Enterprise Value Including Cash) is the firm's total capital footprint — equity + debt + cash + minority interest. The EU's standard intensity measure (SFDR PAI 3) — answers: how much carbon does each million of capital deployed in this business produce?

no peer comparison yet
Asset intensity
Carbon / $m PP&E + leased
tCO2e / $m

PP&E (Property, Plant & Equipment) plus leased real-estate assets is the firm's physical infrastructure on the balance sheet. This shows the carbon intensity of that physical footprint — uses Scope 1+2+3 for consistency with the other headline intensities. Surfaces stranded-asset risk for asset-heavy firms.

no peer comparison yet

Climate action evidence

20 records · 3 sources
Net-zero claim · FY2040 · In corporate strategy · nzt
(updated as of July 2023) • Biogen is committed to achieving Net Zero emissions by 2040 • Reduce scope 3 emissions 90% by 2045 from a 2019 base year (updated as of 2022) • In 2022, Biogen has set a net zero target of 2045 across the entire value chain, guided by SBTi’s net zero corporate standard, and is currently seeking SBTi approval for this goal. (Cf. Biogen's 2021 YEAR IN REVIEW, p. 154) • Reduce absolute scope 1 and 2 GHG emissions 100% (net zero from operations) by 2040 (2019 baseline)
Carbon credits retired
45 tCO2e
1 retirement · FY2024 · third-party verified
Self-declared vs traced(durable + nature-based removals only)
  • Self-declared (FY2024) — removals45 tCO2e
  • Traced by Reverberate — removals45 tCO2e(100%)
✓ Traced retirements substantially match the firm's own claim.
Last traced year · FY2025 · 1,000 tCO2e across 2 retirements
By credit quality
  • Durable removals45 tCO2e(100%)
Retirements by year and credit class
2024
45tCO₂e
Durable removals
Renewable electricity
100 %
Self-reported renewable electricity share, FY2024 · 139.8 GWh
Sources
  • · Puro.earth Registry
  • · berkeley_voluntary_registry
  • · car
Registry retirements are direct evidence; commitments are forward-looking pledges. EPA snapshot covers FY2019–FY2020.

Strategy & approach

How the firm describes its decarbonisation approach in its own words — alongside the headline numbers above. Self-reported, page-cited.

Approach to renewable energy
10 years of 100% renewable electricity; expanding via VPPAs

Biogen marked 10 years of sourcing 100% renewable electricity in all markets where we operate (committed 2014, joined RE100 in 2015). To complement RECs, entered multi-year direct hydropower contracts (2020) for Cambridge and Solothurn. In 2024, entered two new VPPAs (for three total) and Liberty Solar VPPA (~100 MW project, Biogen 20 MW position) came online. Once all three VPPAs are operational, they are expected to cover 100% of electricity use across North America.

Self-reported · FY2024 · p.47
Approach to carbon removals
Biochar carbon removals to address residual Scope 2

To address residual emissions and achieve net-zero market-based Scope 2 emissions, Biogen invested in permanent carbon removals via biochar projects. Biochar is a charcoal-like material created by burning carbon-rich biomass such as agricultural waste in a low-oxygen environment. Purchased 45 tCO2e of CORC 100+ credits certified by Puro.earth to offset municipal steam.

Self-reported · FY2024 · p.47
Primary decarbonisation levers
  • Green chemistry and sustainable lab operations

    100% of labs My Green Lab certified, with 57% Green-level (highest). Working to advance a Development and Commercialization Scorecard for small molecule assets to standardize evaluation of process improvements on efficiency, GHG emissions, waste, and patient safety. Greener chemistry principles: safer processes, reduced solvent use, efficient conversion of key materials.

  • Fleet electrification

    EV and hybrid options available in countries where employees use corporate fleet vehicles. In 2024 added more than a dozen new EV chargers in the U.S. alone for fleet, employees, and visitors.

  • Sustainable packaging and product stewardship

    Purchased new equipment for in-house prototyping of more sustainable cartons, leaflets, instructions for use. Evaluating monolayer blisterpack films (eliminating PVC content), paper bottle and cap closures, and 100% biodegradable trays from potato starch to replace plastic molded trays. Exploring alternatives to single-use injectors.

  • Operational energy efficiency and end-of-life equipment replacement

    Multi-pronged approach to reduce Scope 1: promoting greater efficiency when retiring equipment such as boilers, working to eliminate certain refrigerants, ensuring minimum efficiency standards for priority facilities. Achieved 16% reduction in Scope 1 since 2019 baseline. Examples: RTP chiller software/hardware upgrades avoided new chiller capex; Baar Switzerland air-source heat pump cut natural gas 96% vs 2023. Since 2019, reduced CO2 by 10,421 metric tons.

Dependent decarbonisation levers
  • Supplier engagement on renewables and SBTi targets

    CLEAN (Conscious Logistic Environment Action Network) initiative incorporates environmental impacts in supplier decisions. As of Q1 2025, 56% of top 50% of suppliers by spend pledged to use 100% renewable electricity (more than double prior year). More than 37% of top 80% of suppliers by spend have set or pledged to set science-based climate targets verified by SBTi (16% YoY increase). Enhanced use of EcoVadis to assess supplier programs.

Targets

Near-term

1 target
ScopeBaseTargetReductionAlignmentProgressStatus
Scope 1 + 2 + 3Absolute20192032−55%In corporate strategy
31.0% reductionof −55% target · 56% there
On track

Net zero

1 target
ScopeBaseTargetReductionAlignmentProgressStatus
Scope 1 + 2 + 3Absolute2040In corporate strategyabsolute-value target

⚠ Some targets show progress vs the earliest extracted year as a baseline approximation. The real base-year value will be used once historical reports are extracted.

Progress · absolute tCO2e

Scope 1 + 2 trajectory
ActualLinear1.5°C

No target available for this scope.

Scope 3 trajectory
ActualLinear1.5°C

No target available for this scope.

Latest news· last 5 of 16

full news log →
  • 10 years of 100% renewable electricity; expanding via VPPAs

    Biogen marked 10 years of sourcing 100% renewable electricity in all markets where we operate (committed 2014, joined RE100 in 2015). To complement RECs, entered multi-year direct hydropower contracts (2020) for Cambridge and Solothurn. In 2024, entered two new VPPAs (for three total) and Liberty Solar VPPA (~100 MW project, Biogen 20 MW position) came online. Once all three VPPAs are operational, they are expected to cover 100% of electricity use across North America.

    2024
  • 100% labs My Green Lab certified

    Sustained 100% lab certification through My Green Lab, with 57% achieving Green-level (highest) status. Recertified 14 labs.

    2024
  • Updated emission factors and improved supplier categorization

    Decrease in Cat 1, Cat 2, Cat 4 values due to updated emission factors, change in spend, and improved supplier categorization.

    2024
  • Acquisition of Human Immunology Biosciences (HI-Bio)

    Through the acquisition of HI-Bio, advancing felzartamab for late antibody-mediated rejection in kidney transplant patients.

    2024
  • Two new VPPAs signed; Liberty Solar VPPA came online

    Entered into two new virtual power purchase agreements (for three total). Liberty Solar (~100 MW, Biogen 20 MW position) came online September 2024.

    2024

Latest reporting year· 4 earlier years on Data-by-year tab

all years + ratios →

2026

reporting year
Financials
Revenue
OpEx
FTE
Market cap (FY-end)
Climate
Scope 1
Scope 2 (market)
Scope 2 (location)
Scope 3 total

Source documents· FY2024

all documents →
sustainability report2024
via manual upload · 7.4 MB
extractedOPEN PDF ↗